Navigation Links
Malaria research must be based in Africa
Date:2/22/2010

Gunilla Priebe has studied the international research alliance the Multilateral Initiative on Malaria (MIM), which advocates for malaria research in general and the strengthening of research environments in Africa. Malaria research has historically been controlled by interests located in areas outside Africa. This has led to a huge gap in knowledge in relation to the malaria problems that dominate everyday life in those areas where people are most affected by the disease.

Better opportunities for researchers on site

According to MIM, researchers based in Africa have a more comprehensive understanding of malaria and its effects on the population. In addition, a locally based researcher is often more motivated to solve problems that are of considerable significance for the majority of malaria patients.

"Proximity to the environment where the social, political, economic as well as the biological dynamics related to malaria are evident provides the researcher with better opportunities to formulate relevant research questions. If the research is based in Africa it increases the chances of the results being of some practical use," says Gunilla Priebe.

Africanisation brings fresh approach

Gunilla Priebe's analysis is framed by the concept of "Africanisation", which in relation to scientific knowledge production entails two integrated themes: the meaning of time and location with regard to researchers' ability to represent a study object correctly and in a relevant manner, and partly the impact of remnants of colonialism on the production of scientific knowledge.

According to Gunilla Priebe, the study of MIM shows that Africanisation of malaria research means investments in infrastructure, education and improved forms for research cooperation. In such a case, Africanisation will also lead to innovative approaches when it comes to research methods and arguments, as well as enhanced influence from both patient and researcher groups that have in the past been marginalised within malaria research.

Definition of researcher's role

Based on the conclusions drawn from Theory of science study of MIM, Gunilla Priebe's recommendation to research organisations, such as philanthropic foundations and national aid and research bodies, is to evaluate the role of research for development in the same way as other "foreign" initiated development cooperation.

"Naturally more money for research into malaria is welcomed, but if the organisations that support research in and about Africa don't intend to reproduce colonial methods, then these cannot work on the basis of utopian ideals of scientific autonomy. They must also take such issues as the right to co-ownership at each stage of knowledge production into consideration. Neither can they focus solely on financial support or the content and organisation of the research; they must also engage with the political and social effects of research and research support," says Gunilla Priebe.


'/>"/>

Contact: Gunilla Priebe
gunilla.priebe@theorysc.gu.se
46-31-786-5298
University of Gothenburg
Source:Eurekalert

Related medicine news :

1. Tony Blair Visits Pioneering Interfaith Malaria Initiative in Nigeria
2. UCR researcher identifies mechanism malaria parasite uses to spread in red blood cells
3. Private Sector, President's Malaria Initiative Join Forces to Strengthen Angolas Capacity to Control Mosquitoes
4. One-third of antimalarial medicines sampled in 3 African nations found to be substandard
5. MARA Fights Malaria With WaveMaker and Amazon Web Services
6. Mimotopes Awarded Major Peptide Supply Contract by the Queensland Institute of Medical Research in the Search for an Effective Malaria Vaccine
7. UM School of Medicine scientists find new malaria vaccine is safe and promotes immune response in children
8. Breakthrough by Danish scientists in preventing maternal malaria
9. UM School of Medicine scientists find new malaria vaccine is safe and protective in children
10. Malaria Parasite Infects Gorillas, Not Just Humans
11. WHO World Malaria Report Shows Aid Efforts Are Working
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... A stressful work ... work can also decrease overall productivity and performance in the workplace. The goal of ... During the last few weeks of April, Clearview Resolution Services will be shutting down ...
(Date:4/25/2017)... ... April 25, 2017 , ... Patients who would like to ... a fraction of the time as traditional braces – Wilckodontics®. Dr. Victoria Chen, ... offers this revolutionary treatment with or without a referral. , Wilckodontics is ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, ... continuation of its strategic partnership with and platinum sponsorship of Global Spine Outreach ... safe and effective management of complex spine deformity cases, particularly in children. , ...
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a point ... strategies to reduce waste, and support renewable energy. They believe this is a crucial ... to find solutions for health issues, and maintain that destroying the environment in the ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  CVS Pharmacy, the ... unveiled a new store design to enhance the ... healthier food, health-focused products and expanded beauty selections ... help customers discover new offerings. Together with its ... evolution of the customer experience at CVS Pharmacy.  ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... PARIS , April 20, 2017 ... EyeCET platform, the first non-viral gene expression technology that ... in the eye to address a wide range of ... UK Medicines and Healthcare products Regulatory Agency (MHRA) to ... ...
Breaking Medicine Technology: